CF Industries
CF
$127.86
+2.11%
CF Industries Holding, Inc. is a leading global producer and distributor of nitrogen-based fertilizers, operating primarily in the Agricultural Inputs industry within the Basic Materials sector. The company's distinct competitive identity is that of a low-cost producer, leveraging its access to low-cost US natural gas as a primary feedstock for its manufacturing plants in North America, the UK, and Trinidad and Tobago. The current investor narrative is heavily influenced by geopolitical events affecting global energy and fertilizer supply chains, as recent news highlights the stock's sensitivity to the closure and subsequent reopening of the Strait of Hormuz, which has created significant volatility in commodity prices and margin opportunities for North American producers.…
CF
CF Industries
$127.86
Investment Opinion: Should I buy CF Today?
Rating & Thesis: CF Industries is a HOLD. The core thesis is that the stock's compelling valuation (P/E of 8.62x) and strong cash flows are balanced against clear cyclical and geopolitical risks that limit near-term upside, warranting a neutral stance until greater clarity emerges on the sustainability of current margin levels.
Supporting Evidence: The HOLD rating is supported by four key data points. First, valuation is modest with a trailing P/E of 8.62x, well below its own historical highs near 20x. Second, profitability is strong with a Q4 net margin of 21.6% and gross margin of 41.1%. Third, financial health is excellent, with a debt-to-equity of 0.82 and $1.8B in TTM free cash flow. Fourth, technical momentum is strong but may be peaking, with the stock up 45% over one year but showing deceleration in the most recent month (+3.67%).
Risks & Conditions: The two biggest risks are a collapse in the natural gas-to-fertilizer price spread and a broader de-rating of cyclical materials stocks. This HOLD rating would upgrade to a BUY if the trailing P/E compressed further toward 7x on sustained earnings, or if geopolitical tensions prolong the current margin environment. It would downgrade to a SELL if quarterly revenue growth turns negative or gross margins contract below 35%. Relative to its own history and strong fundamentals, the stock appears fairly valued, not egregiously overvalued, but the cyclical risks prevent a more aggressive rating.
Sign up to view all
CF 12-Month Price Forecast
The outlook for CF is highly contingent on commodity cycles and geopolitics, making a high-conviction directional call difficult. The base case of consolidation is most probable (60%), as the stock has already priced in significant good news but is supported by a cheap valuation and strong cash flows. The key factor is the duration of the current margin environment; evidence of sustainability would justify a move toward the bull case, while a swift normalization would trigger the bear case. The AI's neutral stance reflects this balanced risk/reward, with medium confidence due to the high external uncertainty. A shift to bullish would require evidence that Q4 2025 margin levels (41.1% gross) are sustainable for multiple quarters, while a shift to bearish would be triggered by a breakdown below key technical support at $115.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on CF Industries's 12-month outlook, with a consensus price target around $166.22 and implied upside of +30.0% versus the current price.
Average Target
$166.22
6 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
6
covering this stock
Price Range
$102 - $166
Analyst target range
The stock is covered by 6 analysts, and institutional ratings show a mixed but leaning cautious sentiment, with recent actions including an 'Underperform' from Mizuho and an 'Outperform' from BMO Capital. The consensus recommendation is not explicitly stated in the data, but the distribution of actions suggests a neutral to slightly bearish tilt, with insufficient data to calculate a precise average target price or implied upside/downside. The target range is also not provided in the analyst data, which only includes estimated EPS and revenue ranges; the wide estimated EPS range from $5.90 to $9.74 signals high uncertainty among analysts regarding the company's future earnings power, likely tied to volatile natural gas and fertilizer price forecasts.
Bulls vs Bears: CF Investment Factors
The bullish case for CF is anchored in its strong fundamental performance, attractive valuation, and unique positioning as a geopolitical beneficiary. The bearish case centers on the cyclical nature of its earnings, its sensitivity to reversing commodity price trends, and signs of technical overextension. Currently, the bull side holds stronger evidence due to concrete metrics like a trailing P/E of 8.62x, a 41% gross margin, and $1.8B in TTM free cash flow, which suggest the stock is not excessively priced for its current profitability. The single most important tension in the investment debate is the sustainability of its elevated margins. If geopolitical tensions ease and natural gas-to-fertilizer spreads normalize, the bear case of an earnings decline and valuation de-rating becomes dominant. Conversely, prolonged supply chain disruptions would validate the bull case of sustained super-normal profitability.
Bullish
- Strong Profitability and Margin Expansion: CF's Q4 2025 net margin of 21.58% and gross margin of 41.08% demonstrate robust profitability. This represents a significant 670 basis point expansion in gross margin from 34.32% in Q4 2024, showcasing superior pricing power and operational leverage.
- Attractive Valuation with Low P/E: The stock trades at a trailing P/E of 8.62x, which is historically low for the company and suggests the market is not pricing in overly optimistic earnings expectations. The forward P/E of 12.23x, while higher, still implies a reasonable valuation for a profitable, growing firm.
- Exceptional Free Cash Flow Generation: The company generated $1.80 billion in TTM free cash flow, providing substantial financial flexibility. This strong cash generation supports shareholder returns, reinvestment, and a healthy balance sheet, evidenced by a low debt-to-equity ratio of 0.82.
- Geopolitically-Driven Margin Tailwinds: Recent news highlights the company's position as a low-cost North American producer benefiting from global supply disruptions, such as the Strait of Hormuz closure. This creates a significant margin arbitrage opportunity as global nitrogen prices rise relative to low-cost US natural gas.
Bearish
- Cyclical Earnings Peak and Forward P/E Expansion: The forward P/E of 12.23x is 42% higher than the trailing P/E of 8.62x, indicating the market expects a meaningful decline in earnings from current cyclically high levels. Analyst EPS estimates for the future year range widely from $5.90 to $9.74, reflecting high uncertainty.
- Sensitivity to Commodity Price Reversal: The stock's recent surge is directly tied to geopolitical events boosting fertilizer prices. News of the Strait of Hormuz reopening on April 17, 2026, triggered a 14% oil price crash, signaling a key risk premium removal that could reverse recent margin tailwinds for CF.
- Analyst Sentiment is Mixed to Cautious: Recent analyst actions include an 'Underperform' rating from Mizuho, suggesting professional skepticism about the sustainability of the rally. The lack of a clear consensus target price and wide EPS estimate range points to a lack of conviction in forward earnings.
- Technical Overextension and Consolidation: The stock price at $125.24 is 75% of the distance from its 52-week low ($75.42) to its high ($141.96), suggesting strong momentum but potential overextension. The 1-month gain of +3.67% has decelerated sharply from the 3-month gain of +32.31%, indicating a potential consolidation phase.
CF Technical Analysis
The stock is in a sustained uptrend, evidenced by a 1-year price change of +45.24% and a 6-month change of +47.27%. With a current price of $125.24, it is trading approximately 75% of the distance from its 52-week low of $75.42 toward its high of $141.96, indicating strong momentum but not yet at peak overextension. Recent momentum shows a slight deceleration from the longer-term trend, with a 3-month gain of +32.31% outpacing a more modest 1-month gain of +3.67%, suggesting a potential consolidation phase after a powerful rally. The stock's beta of 0.417 indicates it has been significantly less volatile than the broader market, a notable characteristic during a period of high geopolitical uncertainty. Key technical levels are clearly defined, with the 52-week high of $141.96 acting as major resistance and the 52-week low of $75.42 as foundational support; a breakout above resistance would signal a resumption of the primary bull trend, while a breakdown below support would challenge the uptrend's validity.
Beta
0.42
0.42x market volatility
Max Drawdown
-25.8%
Largest decline past year
52-Week Range
$75-$142
Price range past year
Annual Return
+46.0%
Cumulative gain past year
| Period | CF Return | S&P 500 |
|---|---|---|
| 1m | +13.5% | +3.3% |
| 3m | +33.4% | +6.9% |
| 6m | +64.4% | +12.4% |
| 1y | +46.0% | +23.4% |
| ytd | +59.6% | +7.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CF Fundamental Analysis
Revenue growth has been robust, with Q4 2025 revenue of $1.87 billion representing a 22.83% year-over-year increase, and the multi-quarter trend shows consistent strength, with Q3 and Q2 2025 revenues at $1.66 billion and $1.89 billion, respectively. The company is highly profitable, with Q4 2025 net income of $404 million and a net margin of 21.58%, while gross margins have expanded impressively, reaching 41.08% in Q4 2025 compared to 34.32% in Q4 2024, indicating significant operational leverage and pricing power. Financial health is solid, supported by a strong current ratio of 3.37, a manageable debt-to-equity ratio of 0.82, and substantial free cash flow generation, with TTM free cash flow of $1.80 billion providing ample internal funding for growth initiatives and shareholder returns.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.22%
YoY Comparison
Gross Margin
+0.41%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CF Overvalued?
Given a positive net income of $404 million in the latest quarter, the primary valuation metric is the P/E ratio. The trailing P/E is 8.62x, while the forward P/E is 12.23x; the higher forward multiple suggests the market expects some moderation in earnings growth from recent cyclically high levels. Compared to sector averages, the stock's trailing P/E of 8.62x and PS ratio of 1.77x appear modest, but a direct industry average is not provided in the data for a quantified premium/discount analysis. Historically, the stock's current trailing P/E of 8.62x sits well below its own historical range observed in the data, which has seen ratios as high as 20.15x in early 2024, suggesting the current valuation may not be pricing in overly optimistic expectations despite the strong price performance.
PE
8.6x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range -16x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
4.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: CF's primary financial risk is earnings cyclicality, not balance sheet weakness. The company's robust free cash flow ($1.8B TTM) and solid liquidity (current ratio of 3.37) mitigate near-term solvency concerns. However, the core operational risk is margin compression; the recent gross margin expansion to 41.1% is likely near a cyclical peak. A reversion to the mean, as suggested by the higher forward P/E of 12.23x versus the trailing 8.62x, could significantly pressure net income from its current $404M quarterly run-rate. Revenue, while growing at 22.8% YoY in Q4, is inherently volatile and tied to commodity prices.
Market & Competitive Risks: The stock's greatest market risk is a valuation de-rating driven by a normalization of the geopolitical risk premium. The stock's recent surge is directly linked to events like the Strait of Hormuz closure, and news of its reopening on April 17, 2026, has already introduced volatility. While CF's beta of 0.417 indicates low market correlation, its sector-specific correlation to energy and agriculture commodities is high. Competitive risks are mitigated by its low-cost producer status, but the industry remains capital-intensive and subject to global trade flows and regulatory changes impacting fertilizer use.
Worst-Case Scenario: The worst-case scenario involves a rapid normalization of global energy and fertilizer markets, compounded by a downturn in the agricultural cycle. This would squeeze the company's margin spread between low-cost US natural gas and global fertilizer prices. Analyst EPS estimates suggest a potential low of $5.90, which, if priced at a depressed multiple, could drive the stock toward its 52-week low of $75.42. From the current price of $125.24, this represents a potential downside of approximately -40%. A drawdown of this magnitude is plausible given the stock's historical max drawdown of -25.75% within the recent data period.
FAQ
The key risks are: 1) Commodity & Geopolitical Risk: Earnings are directly tied to volatile fertilizer and natural gas prices, which are currently inflated by Middle East tensions. News of the Strait of Hormuz reopening is a prime example of this risk materializing. 2) Cyclical Downturn Risk: The forward P/E of 12.23x signals an expected earnings decline; a sharp agricultural downturn could accelerate this. 3) Concentration Risk: As a pure-play nitrogen producer, CF lacks diversification. 4) Sentiment Risk: Analyst sentiment is mixed with an 'Underperform' rating recently issued, and the stock's 45% 1-year gain leaves it vulnerable to profit-taking.
The 12-month forecast is bifurcated, with a 60% probability base case target range of $115-$130, a 25% probability bull case target of $141-$155, and a 15% probability bear case target of $75-$95. The base case, which is most likely, assumes a moderation of the recent geopolitical premium and a consolidation of earnings, leading the stock to trade sideways from current levels. The wide range of analyst EPS estimates ($5.90 to $9.74) underscores the high degree of uncertainty in this forecast, which hinges almost entirely on the path of global fertilizer prices and spreads.
CF appears fairly valued to slightly undervalued based on trailing earnings, but the market is pricing in a decline. The trailing P/E of 8.62x is low both historically (the stock has traded above 20x) and relative to its current profitability (21.6% net margin). However, the forward P/E of 12.23x is 42% higher, indicating the market expects earnings to fall. Using a blended view, the stock is not egregiously overvalued, but the valuation implies the market expects a reversion from peak cyclical margins, not further expansion.
CF presents a nuanced opportunity. For value-oriented investors comfortable with commodity cyclicality, its trailing P/E of 8.62x and strong free cash flow yield are compelling. The stock has significant analyst-estimated upside if it reaches its 52-week high of $141.96, but this is balanced against the risk of earnings peaking. It is a good buy for investors seeking exposure to the agricultural/energy complex who can tolerate volatility and are bullish on sustained geopolitical tensions. It is not a good buy for investors seeking stable, predictable growth or who are concerned about a rapid normalization in commodity markets.
CF is more suitable for medium- to long-term investors who can weather the commodity cycle. While short-term traders may capitalize on geopolitical volatility, the stock's low beta of 0.417 and cyclical nature make it a better fit for a strategic, long-term portfolio holding. The company's strong free cash flow generation supports consistent capital returns, and its low-cost structural advantage is a durable long-term asset. A minimum holding period of 2-3 years is suggested to allow for the completion of a potential commodity cycle and for the company's investments in green ammonia to potentially gain recognition.